Similarly, adenoviral anti-FAP vaccines are able to selectively deplete CAFs by stimulating a CD8+ T cell response, leading to the inhibition of tumor growth and metastasis in several murine cancer models [163,164,165,166]. The gene discussed is FAP; the disease is cancer.